Authors
Latest:
Cost considerations in the management of bladder cancer"We will review the evidence and identify potential areas of improvement that can help reduce costs associated with UCB management while improving outcomes," write Daniel J. Lee, MD, and Sam S. Chang, MD.
Latest:
Marijuana use prevalent among chronic prostatitis/chronic pelvic pain syndrome patientsWith marijuana legalized for medical use in Canada since 2001 and now in 17 U.S. states and the District of Columbia, urology patients in pain have been turning to marijuana for relief.
Latest:
Report urges action on physician burnoutA new report by the National Academy of Medicine urges action by government, educational institutions, and health care organizations to address the causes of physician burnout, which is experienced by up to one-half of clinicians in the U.S. and threatens patient care.
Latest:
23 years of helping urologists play physicians’ MonopolyI wanted to take this opportunity to say thank you to all who have read my “Coding and Reimbursement” and “Coding Q&A” articles for the past 23 years.
Latest:
2024 Medicare final rule: Here comes code G2211"The conversion factor is slated to undergo a reduction of approximately 3.37% for 2024, decreasing from $33.89 in 2023 to $32.74," write Jonathan Rubenstein, MD, and Mark Painter.
Latest:
Prostate cancer study highlights complexity of ‘appropriate’ care"Deciding what care is appropriate is already extraordinarily difficult but will be a growing problem for the next generation of physicians and society," writes Peter C. Albertsen, MD.
Latest:
'Medical home' gaining traction, but at what cost?The controversial concept of medical home calls for a team led by a physician, usually a primary care physician, to be paid extra to handle personalized coordination of a patient's care across the health care system, including acting as liaison with other providers.
Latest:
Renal AML: The role of laparoscopic cryoablationFive-year recurrence and disease-free survival rates for laparoscopic cryoablation are equivalent to those of standard open surgical techniques.
Latest:
Prostate cancer treatments: Assessing effects on quality of lifeThe most instructive HRQoL studies are those that rely on prospective, longitudinal assessments of patients using a validated instrument.
Latest:
Prostate cancer treatments: Assessing effects on quality of lifeThe most instructive HRQoL studies are those that rely on prospective, longitudinal assessments of patients using a validated instrument.
Latest:
Treatment of VUR: The bar is raised, morbidity loweredThe treatment paradigm for vesicoureteral reflux has undergone a significant shift in recent years. Endoscopic surgery has provided an effective, minimally invasive option that is gradually eliminating the need for prolonged antibiotic use, monitoring with voiding cystourethrograms (VCUGs), and open surgery in children with most grades and forms of VUR.
Latest:
Active Surveillance in Muscle Invasive Bladder CancerTypes of patients with muscle invasive bladder cancer who may be candidates for a watch-and-wait approach.
Latest:
Prostate biopsies: How well do they predict tumor location?Although needle biopsies are being used for localization, the majority of prostate cancers are multifocal in nature and invisible on gray scale ultrasonography.
Latest:
How to restart your practice when the COVID-19 red light turns green"In the current environment of coronavirus disease 2019 (COVID-19), it has become obvious that it won’t be business as usual when the economy restarts and social distancing restrictions are relaxed," write Steven A. Kaplan, MD, and Alexis E. Te, MD.
Latest:
Endoscopic robotic platforms: What the future holdsThis article highlights some of the emerging endoscopic robotic systems in urology.
Latest:
Robotic ureteroscopy: The future of stone management?Advances in robotic URS will help target stones and reduce ionizing radiation.
Latest:
Good and bad news: ED patients often don't returnQuebec City, Quebec--The good news is that most patients being treated for erectile dysfunction report that their treatment is working. The bad news is that a significant percentage of these same patients are often lost to follow-up for that very reason, according to a study by urologists from McGill University.
Latest:
CP/CPPS therapies may yield long-sought answersResearch has begun to examine a range of novel treatment modalities, some with quite promising results.
Latest:
Nocturia: Data point to multiple etiologiesRecent studies suggest that nocturia has many etiologies, including urologic, metabolic, and perhaps most important, behavorial.
Latest:
Stark II in 2003: What urologists still need to knowEven after the tremendous victory won by the American Lithotripsy Society and the Urology Society of America last year in federal court, urologists still must be concerned with Stark II and the federal anti-kickback statute.
Latest:
Stark II in 2003: What urologists still need to knowEven after the tremendous victory won by the American Lithotripsy Society and the Urology Society of America last year in federal court, urologists still must be concerned with Stark II and the federal anti-kickback statute.
Latest:
The physician executive: How one urologist balances MD, CEO rolesIn this interview, physician executive J. Christian Winters, MD, outlines his multiple professional roles, explains how he divides his time between clinical and administrative responsibilities, and offers advice to young urologists seeking a career in leadership.
Latest:
Stark II in 2003: What urologists still need to knowEven after the tremendous victory won by the American Lithotripsy Society and the Urology Society of America last year in federal court, urologists still must be concerned with Stark II and the federal anti-kickback statute.
Latest:
The promise of PD-1 ligand pathway in treating bladder cancerResearchers have recently made progress in understanding a fundamental signaling cascade, the Programmed Death 1 (PD-1) receptor-ligand pathway,1 which holds long-awaited promise in bladder cancer intervention.
Latest:
Transgender surgery: Videos demonstrate cutting-edge techniquesIn these videos, expert surgeons demonstrate robot-assisted penile inversion vaginoplasty, single-stage metoidioplasty, and simple orchiectomy for transgender patients.
Latest:
Botulinum formulations show slight outcomes differencesA new comparative study showed that the use of intradetrusor injections of abobotulinum toxin A (Dysport) for urinary incontinence due to neurogenic detrusor overactivity provided results that were similar to or superior to those seen with onabotulinum toxin A (Botox), depending on the dosage of the latter.
Latest:
Adjuvant therapy fails in locally advanced kidney CaTwo angiogenesis inhibitors that are widely used in metastatic renal cell carcinoma did not improve survival compared with placebo when used as adjuvant treatment, a new study found.
Latest:
MIPS 2020: How did urologists fare with quality program?Almost all clinicians avoided negative fee schedule adjustment in 2022.
Latest:
Expert pointers on BPH evaluation and treatmentIn this interview, Alexis E. Te, MD, discusses the evolution of LUTS treatment, what primary care providers should include in their evaluation when seeing a patient with LUTS, and how he selects treatments for patients with BPH.
Latest:
Research on bladder tissue regeneration progressesAtlanta-Tissue engineering research has grown by leaps and bounds in the past decade and a half, yielding findings that may someday have a profound impact on the field of pediatric urology. At the 2006 American Academy of Pediatrics Section on Urology annual meeting here, several groups presented cutting-edge data on novel systems for organ generation, including research demonstrating the feasibility of generating a functioning bladder from stem cells.
